Search

Your search keyword '"van Laar, Jacob M."' showing total 789 results

Search Constraints

Start Over You searched for: Author "van Laar, Jacob M." Remove constraint Author: "van Laar, Jacob M."
789 results on '"van Laar, Jacob M."'

Search Results

1. Hematopoietic Stem Cell Transplantation

5. Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study

7. Contributors

8. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

10. A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

12. Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands

14. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

15. Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

22. Systemic Sclerosis

27. AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.

30. Prognostication of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung diseases: A cohort study

31. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

32. Additional file 1 of Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients

36. Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

40. Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation

41. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria

42. Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

50. Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison

Catalog

Books, media, physical & digital resources